Table 3:
Summary of Smoking Cessation Interventions
| Author/Year | Interventions |
|---|---|
| Chen/2014 | Brief counseling, Telephone interview, Buproprion 150mg orally |
| Cooley 2007 | 19% received counseling, 31% received education, and 89% used nicotine replacement treatment |
| Cooley 2009 | 46% of those who were smoking at diagnosis received cessation assistance with pharmacotherapy being the most common strategy: Bupropion only 24%, NRT only 24%, Bupropion + NRT 6%, Bupropion + information 6%, Information + NRT 18%, Counseling + pharmacotherapy 6% |
| deBruin-Visser 2012 | Counseling, patch (26%), lozenges (12%), Buproprion (2%), combination lozenges and patch (21%), combination patches and buproprion (1%) |
| Farley 2016 | NR |
| Gulmond 2014 | NR |
| Humphris 2004 | NR |
| Krebs 2019 | Behavioral, NRT in 37.5% |
| Maher 2003 | NR |
| Martinez 2018 | Behavioral |
| Matulewicz 2021 | Behavioral (advised to quit smoking by health professional) |
| Naresh 2020 | NR |
| Ostroff 2013 | Behavioral + NRT |
| Ostroff 1995 | Physician recommendations (39%), Support from family and friends (35%), NRT (31%) |
| Park 2020 | Behavioral + pharmacologic (NRT, Buproprion, Varenicline) |
| Paul 2019 | NR |
| SandersonCox 2002 | NR |
| Schnoll 2003 | NR |
| Schnoll 2002 | NR |
| Sheikh 2021 | NR |
| Simmons 2013 | NR |
| Simmons 2020 | Behavioral |
| Smailey 2021 | Behavioral and NRT |
| Smith 2020 | Behavioral and option of NRT |
| Smith 2021 | Behavioral and option of NRT |
| Tomek 2003 | NR |
| Vitzthum 2015 | behavioral (CBT, acupuncture, hypnosis, books, etc) and pharmacologic: NRT (9.8% ex-smokers, 24.1% smokers), varenicline (2.2% ex-smokers, 0% smokers), bupropion (0% ex-smokers, 3.4% smokers) |
| Walker 2004 | NRT (26%) |
| Walker 2006 | NRT (13.1%) |
NR=Not Recorded, NRT=Nicotine Replacement Therapy, CBT=cognitive behavioral therapy